Publications

Publications

Filter Results: (1,298) Arrow Down
Filter Results: (1,298) Arrow Down Arrow Up

Show Results For

Show Results For

← Page 20 of 1,298 Results →
  • December 2007
  • Article

China + India: The Power of Two

By: Tarun Khanna
China and India are burying the hatchet after four-plus decades of hostility. A few companies from both nations have been quick to gain competitive advantages by viewing the two as symbiotic. If Western corporations fail to do the same, they will lose their competitive... View Details
Keywords: Competency and Skills; Economic Growth; Cross-Cultural and Cross-Border Issues; Multinational Firms and Management; Business History; Competitive Strategy; Cooperation; China; India
Related
  • 2012
  • Chapter

China: The Indigenization of Insurance

By: Elisabeth Koll and David Faure
The concept of insurance was introduced to China in the early nineteenth century by Westerners trading in Guangzhou and practised essentially among them. We argue that indigenization of insurance, in particular life insurance, was a slow process that stretched from the... View Details
Keywords: History; Insurance; Insurance Industry; China
Related
  • 06 Aug 2021
  • Blog Post

Socioeconomic Inclusion at HBS: Alexis Jackson (MBA 2021)

industry that would bring financial and job security. An aptitude for math and science led to an engineering scholarship to Penn State, a major in electrical engineering, and a position at a multinational oil and gas corporation after... View Details
  • September 2015
  • Article

Codes in Context: How States, Markets, and Civil Society Shape Adherence to Global Labor Standards

By: Michael W. Toffel, Jodi L. Short and Melissa Ouellet
Transnational business regulation is increasingly implemented through private voluntary programs—like certification regimes and codes of conduct—that diffuse global standards. But little is known about the conditions under which companies adhere to these standards. We... View Details
Keywords: Transnational Regulation; Labor Standards; Consumer Politics; Codes Of Conduct; Compliance; Governance Compliance; Operations; Globalization; Labor
Related
  • November 2017
  • Case

The 'Wonder Drug' That Killed Babies

By: Joshua Lev Krieger, Tom Nicholas and Matthew Preble
In the early 1960s, a popular drug taken by patients worldwide for a range of maladies was found to cause severe birth defects and other health problems in babies born to mothers who had taken it during a certain stage of fetal development. As many as 10,000 children... View Details
Keywords: Regulation; Business and Government Relations; Business and Community Relations; Business and Stakeholder Relations; Product Marketing; Corporate Social Responsibility and Impact; Business History; Health; Government Legislation; Corporate Accountability; Ethics; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; Pharmaceutical Industry; United States; United Kingdom; Australia; Germany; Europe
Related
  • 26 Dec 2012
  • Working Paper Summaries

Reinforcing Regulatory Regimes: How States, Civil Society, and Codes of Conduct Promote Adherence to Global Labor Standards

Keywords: by Michael W. Toffel, Jodi L. Short & Melissa Ouellet
  • November 2005 (Revised September 2007)
  • Case

Beijing Hualian

By: David E. Bell and Mary L. Shelman
China's fifth largest domestic retailer faced intensifying competition from Wal-Mart and Carrefour with the opening of China's fast-growing retail market in January 2005. In response, Beijing Hualian developed a new "Family Store" format targeted at the nation's... View Details
Keywords: Marketing Strategy; Product Positioning; Consumer Behavior; Competition; Corporate Strategy; Retail Industry; China
Related

    Jay W. Lorsch

    Jay W. Lorsch is the Louis Kirstein Professor of Human Relations at the Harvard Business School. He is editor of View Details

      Michael Beer

      MICHAEL BEER

      Mike Beer is the Cahners-Rabb Professor of Business Administration, Emeritus at the Harvard Business School and author Fit to Compete: Why Honest Conversations About Your Company’s... View Details

      • April 2025 (Revised June 2025)
      • Case

      Governing Sustainability in a Shifting Context (A)

      By: Lynn S. Paine and Will Hurwitz
      In early 2025, boards of directors had to rethink corporate responsibility and sustainability efforts amid rapidly-shifting social, legal, regulatory, and economic forces. While just a few years earlier, calls to address racial justice and climate change reached into... View Details
      Keywords: Climate Change; Corporate Governance; Diversity; Leadership; Business or Company Management; Mission and Purpose; Social Media; Race; Environmental Sustainability; Governing Rules, Regulations, and Reforms; Governing and Advisory Boards; Lawfulness; Lawsuits and Litigation; Measurement and Metrics; Corporate Social Responsibility and Impact; Business and Shareholder Relations; Social Issues; Retail Industry; Food and Beverage Industry; Banking Industry; United States
      Related
      • May 2023 (Revised June 2023)
      • Case

      Novartis (A): Reimagining Medicine

      By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
      This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
      Keywords: Health Care and Treatment; Business Model; Leadership; Pharmaceutical Industry; Switzerland
      Related
      • January 2014 (Revised December 2014)
      • Case

      GenapSys: Business Models for the Genome

      By: Richard G. Hamermesh, Joseph B. Fuller and Matthew Preble

      GenapSys, a California-based startup, was soon to release a new DNA sequencer that the company's founder, Hesaam Esfandyarpour, believed was truly revolutionary. The sequencer would be substantially less expensive—potentially costing just a few thousand dollars—and... View Details

      Keywords: DNA Sequencing; Life Sciences; Business Model; Innovation ＆ Entrepreneurship; Health Care and Treatment; Genetics; Business Strategy; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States
      Related
      • May 2023 (Revised June 2023)
      • Supplement

      Novartis (B): Reimagining Medicine

      By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
      This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
      Keywords: Health Care and Treatment; Business Model; Production; Business Strategy; Pharmaceutical Industry
      Related
      • July–August 2015
      • Article

      Engineering Reverse Innovations: Principles for Creating Successful Products for Emerging Markets

      By: Amos Winter and Vijay Govindarajan
      Multinationals are starting to catch on to the logic of reverse innovation, in which products are designed first for consumers in low-income countries and then adapted into disruptive offerings for developed economies. But only a handful of companies have managed to do... View Details
      Keywords: Innovation Strategy; Emerging Markets
      Related
      • January–February 2013
      • Article

      When the Crowd Fights Corruption

      By: Paul M. Healy and Karthik Ramanna
      Corruption is the greatest impediment to conducting business in Russia, according to leaders recently surveyed by the World Economic Forum. Indeed, it's a problem in many emerging markets, and businesses have a role to play in combating it, according to Healy and... View Details
      Keywords: Corruption; Emerging Economies; Crime and Corruption; Entrepreneurship; Ethics; Globalization; Russia; Georgia (nation, Asia); India
      Related
      • Research Summary

      The Transparency of Ethical Behavior

      (with Max Bazerman, Karim Kassam, and Neeru Paharia)
      This research analyzes how unethical behavior is viewed when performed... View Details
      • 06 Jun 2023
      • Cold Call Podcast

      The Opioid Crisis, CEO Pay, and Shareholder Activism

      Keywords: Re: Suraj Srinivasan; Pharmaceutical; Pharmaceutical; Pharmaceutical
      • 2021
      • Article

      How Top Managers Use the Entrepreneurial Gap to Drive Strategic Change

      By: Robert L. Simons and Antonio Davila
      Prior research provides strong evidence for the association between business strategy and the design and use of management control systems. We complement this research by examining the role of management control systems in situations of strategic change. We report the... View Details
      Keywords: Management Control Systems; Accountability; Strategic Change; Organization Change And Adaptation; Organizational Performance; Management Systems; Organizational Structure; Corporate Accountability; Organizational Change and Adaptation; Performance
      Related
      • October 2012 (Revised September 2014)
      • Case

      Doing Business in Vietnam

      By: Alan MacCormack, Michael Shih-ta Chen and Dawn H. Lau
      This case gives an overview of the current business environment in Vietnam as of 2012. The first part of the case introduces the main economic, political and cultural aspects of the country of which anyone who has business interest in the country ought to be aware.... View Details
      Keywords: Emerging Market Finance; Emergent Countries; Business History; Economic History; Emerging Markets; Business Ventures; Strategy; Viet Nam
      Related
      • Research Summary

      Creating Trust in International Joint Ventures in Asia: An Empirical Comparative Study

      In the wake of the currently ongoing financial crisis in Asia, we anticipate a rapid increase of international joint ventures between Asian and Western firms. However, so far, the sources of success in international joint ventures have not been well understood. Why do... View Details